Quick Dispatch:
Your tirzepatide children A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS) orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide children A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS) ships.
Need Help?
Questions about tirzepatide children A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS), sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide children A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS) in your area.
Pediatric trials aim to expand GLP-1 weight loss drugs to younger children
25.97
FDA reconsidering its decision to take tirzepatide off its drug shortage list
22.96
Mounjaro® (tirzepatide) injection and Zepbound® (tirzepatide) injection
20.80
Tirzepatide effective in reducing A1c in children, adolescents with type 2 diabetes
23.67
Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial
26.07
Why the FDA Approved Mounjaro for Children Age 10+ with Type 2 Diabetes
25.39
Same mom, just healthier 💪✨ 45 pounds down with tirzepatide—and more importantly, I finally stopped hiding behind the camera. This isn't about becoming someone new… it's about showing up as the mom
26.50
